drugset / Trial / NCT02198352
Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the present study is to obtain information about the safety, tolerability and pharmacokinetics of BIBN 4096 BS after single intravenous administration of increasing doses in healthy male and female volunteers
Timeline
- Start
- 1998-06
- Primary completion
- 1998-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OLCEGEPANT | Small molecule | — | Intravenous |
Indications
No indication recorded.